Skip to main content
Clinical Trials/NCT04007926
NCT04007926
Suspended
Not Applicable

Effects of Exercise Training on Insulin Sensitivity in South Asians at Risk of Diabetes: the Roles of Skeletal Muscle Microvasculature and Mitochondrial Metabolism

University of Glasgow1 site in 1 country66 target enrollmentAugust 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Insulin Resistance
Sponsor
University of Glasgow
Enrollment
66
Locations
1
Primary Endpoint
Whole-body Insulin sensitivity
Status
Suspended
Last Updated
5 years ago

Overview

Brief Summary

This study determines the effect of aerobic and resistance exercise training on whole-body and skeletal muscle insulin sensitivity in south Asians and evaluate the mechanisms which contribute to improvements in insulin sensitivity after exercise training.

Detailed Description

South Asians (SA) have 2-4 fold higher risk of type 2 diabetes and develop the disease at lower body weights and younger ages than white Europeans. Lower cardiorespiratory fitness and capacity for muscle fat oxidation contributes substantially to SAs' greater insulin resistance, the extent to which this can be improved by exercise training is unclear. This randomised controlled trial will investigate the effects of a 12-week aerobic or resistance exercise training intervention on insulin sensitivity (hyperinsulinaemic-euglycaemic clamp) in South Asian adults (22 control, 22 aerobic exercise group and 22 resistance exercise group). The study will also explore the mechanisms within skeletal muscle which mediate these changes by evaluating aerobic and resistance exercise-training induced changes: in basal and insulin-stimulated microvascular blood volume (using contrast-enhanced ultrasound); skeletal muscle mitochondrial function; and lipid droplet morphology and spatial interaction with mitochrondria, muscle fibre capillarisation, endothelial content of key enzymes controlling dilation/constriction and GLUT-4 translocation (using confocal immunofluorescence microscopy and transmission electron microscopy methods). Thus, this work will integrate physiological and molecular data to determine the extent to which exercise training can improve insulin sensitivity in SA and the mechanisms underpinning this improvement. This knowledge is important for optimising diabetes prevention interventions in SAs and identification of potential novel therapeutic targets.

Registry
clinicaltrials.gov
Start Date
August 2021
End Date
January 2025
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Professor Jason Gill

Professor

University of Glasgow

Eligibility Criteria

Inclusion Criteria

  • South Asian ethnicity (self-report of both parents of Indian, Pakistani, Bangladeshi or Sri Lankan origin)
  • Age 30-65 years
  • At least 10% 10-year risk of developing type 2 diabetes, determined using the QDiabetes®2018 risk score (http://qdiabetes.org/2018/index.php)

Exclusion Criteria

  • Diabetes (physician diagnosed or HbA1c ≥48 mmol/mol on screening)
  • History of cardiovascular disease
  • Hypertension (taking anti-hypertensives or BP consistently ≥ 150/90 mmHg on screening).
  • Regular participation in vigorous physical activity
  • Regular participation in resistance exercise
  • Current smoking
  • Taking drugs or supplements thought to affect carbohydrate or lipid metabolism
  • Taking drugs affecting blood clotting (e.g. aspirin)
  • Current treatment with anti-obesity drugs
  • Any other significant illness that would prevent full participation in the study

Outcomes

Primary Outcomes

Whole-body Insulin sensitivity

Time Frame: Change between baseline and 12 weeks.

Change in whole-body insulin sensitivity measured by hyperinsulinaemic-euglycaemic clamp.

Secondary Outcomes

  • Insulin-stimulated GLUT4 translocation(Change between baseline and 12 weeks.)
  • Microvascular blood volume(Change between baseline and 12 weeks.)
  • Muscle mitochondrial function(Change between baseline and 12 weeks.)
  • Lipid droplet content in skeletal muscle(Change between baseline and 12 weeks.)
  • Lipid droplet proximity to mitochondria in skeletal muscle(Change between baseline and 12 weeks.)
  • Microvascular density in skeletal muscle(Change between baseline and 12 weeks.)
  • Change in enzymes controlling insulin-mediated increases in perfusion in skeletal muscle(Change between baseline and 12 weeks.)
  • Maximal oxygen uptake(Change between baseline and 12 weeks.)
  • Muscle maximal voluntary contraction(Change between baseline and 12 weeks.)
  • Lower body muscle strength(Change between baseline and 12 weeks.)
  • Upper body muscle strength(Change between baseline and 12 weeks.)
  • Grip strength(Change between baseline and 12 weeks.)
  • Weight(Change between baseline and 12 weeks.)
  • Waist circumference(Change between baseline and 12 weeks.)
  • Fat mass(Change between baseline and 12 weeks.)
  • Fat-free mass(Change between baseline and 12 weeks.)

Study Sites (1)

Loading locations...

Similar Trials